PTEN and cancer: PI3K/AKT activation is a common event in cancer progression, either by loss of PTEN (phosphatase and tensin homolog) or activation of receptor tyrosine kinases by stimuli such as TGF-α or VEGF [59] the latter being highly upregulated in clear cell renal cancer.